National award signifies a formal commitment to continuous improvementin quality care. LOUISVILLE, Ky., June 2, 2023 /PRNewswire/ — Continuing its mission to become the Best Healthcare Company in the Midwest, 56 Trilogy Health Services communities across four states have been recognized as 2023 recipients of the Bronze – Commitment to Quality Award by the American … Read more
HOUSTON, June 2, 2023 /PRNewswire/ — Allergy & ENT Associates, a leading provider of allergy and ear, nose, and throat (ENT) care, is announcing the opening of its new office in River Oaks. The new office is located at 2415 W Alabama St STE 208 in Houston, Texas, and is open Tuesday through Friday with … Read more
GRANVILLE, Ohio, June 2, 2023 /PRNewswire/ — Better Minds Group, an advanced behavioral health practice in Licking County, announced today that Amy Klinger, MSN, FNP-BC, President of Recovery NP, will be their latest collaborative partner. Amy Klinger, MSN, Family Nurse Practitioner, has over 20 years experience working with clients struggling with a wide array of challenges, … Read more
WALTHAM, Mass., June 2, 2023 /PRNewswire/ — Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on June 1, 2023 the Company granted inducement awards to purchase up to 397,900 shares of common stock to eighteen new employees under the Company’s 2023 Inducement Plan. The stock … Read more
PHILADELPHIA, June 2, 2023 /PRNewswire/ — More than 500 students from Philadelphia College of Osteopathic Medicine (PCOM) celebrated the culmination of years of hard work and dedication at the College’s 132nd commencement ceremony on May 19 at the Pennsylvania Convention Center in Philadelphia. PCOM Provost and Senior Vice President of Academic Affairs Kenneth J. Veit, … Read more
Clario joins partnership supporting White House Cancer Moonshot Clario brings over 50 years of experience in oncology clinical trials to the partnership and has been involved in over 75% of all FDA approvals of oncology medicines since 2012 Clario scientists have supported nearly 5,000 studies in oncology in over 160,000 sites worldwide involving more than … Read more
Clario joins partnership supporting White House Cancer Moonshot Clario brings over 50 years of experience in oncology clinical trials to the partnership and has been involved in over 75% of all FDA approvals of oncology medicines since 2012 Clario scientists have supported nearly 5,000 studies in oncology in over 160,000 sites worldwide involving more than … Read more
DUBLIN, June 2, 2023 /PRNewswire/ — The “Gene Editing Technologies Market – A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Region – Analysis and Forecast, 2023-2032” report has been added to ResearchAndMarkets.com’s offering. The global gene editing technologies market was valued at $1.81 billion in 2022 and is anticipated to reach … Read more
NEW YORK, June 2, 2023 /PRNewswire/ — Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, announces preliminary data from a Phase 2 clinical trial of the company’s lead therapeutic candidate, PT-112, in patients with recurrent thymic epithelial tumors (TETs), specifically thymoma and thymic carcinoma. The trial is being conducted under … Read more
RADNOR, Pa., June 2, 2023 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced it will host a corporate and strategic update conference call on Monday, June 5, 2023 at 8:30 a.m. EDT. A live webcast of the conference call will be available on the Company’s website … Read more